United Theranostics

Glen Burnie, Maryland 21061

5 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Cervical Adenocarcinoma, Cholangiocarcinoma, Clear Cell Renal Cell Carcinoma, Colorectal Adenocarcinoma, Colorectal Neoplasms, Esophageal Neoplasms, Extrapulmonary Neuroendocrine Carcinoma (EP-NEC), Gastroenteropancreatic NEC (GEP NEC), Head and Neck Cancer, Hormone Receptor Positive Breast Adenocarcinoma

Studies at this site

• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors — Recruiting now
• The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) — Recruiting now
• A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors — Recruiting now
• Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer — Recruiting now
• Phase 1 Study of CLR 125 in Triple Negative Breast Cancer — Recruiting now
• Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors — Recruiting now
• A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer — Stopped early
• 89Zr-DFO-girentuximab Expanded Access Program (EAP) — NO_LONGER_AVAILABLE
• Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy — Running, not enrolling
• FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Running, not enrolling
• Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) — Stopped early